progress loss muscle mass characters mani muscular dystrophy impair efficacy gene molecular therapy current pursue treatment discord become increasingly revid therapeutic applied effect need target mater myofib also progenitor cell stem abl form new tissue restore lost result disease normal homeostasis guarantee last effect correct gene defect use oligodeoxynucleotid on engine nuclear hold great potent musculoskeletal encourage result obtain studi vitro system model organ set groundwork like become emerge field area rgen medicine furthermore bail iso expand patient various type progenitor capable commit myeon linear provide opportun establish cell line use transplant follow ex vivo manipul expand purpose article provide respect approach aim correct edit strategy develop duchess dystrophy dmy sever neuromuscular emphasis place describe patient source challenge technology face biology 